BioCryst Pharmaceuticals, Inc.
BCRX · NASDAQ
Bulios Fair Price
$12.94
49.1% upside
Trenutna cena
$8.68
Po podatkih Bulios Fair Price je delnica BCRX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
BioCryst Pharmaceuticals, Inc. (BCRX) is an American biotechnology company specializing in research, development, and commercialization of therapeutic compounds for the treatment of rare and serious diseases. With a primary focus on developing drugs for rare metabolic disorders and infections, BioCryst Pharmaceuticals leads innovations in therapeutic approaches. The company is known for its advanced technologies and successful clinical trials, which strengthen investor confidence. BioCryst Pharmaceuticals, Inc. (BCRX) shares could be suitable for investors seeking opportunities in the biotechnology sector with an emphasis on drug development for rare diseases.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Charles K. Gayer
Employees
435
Headquarters
Durham
Prihajajoči dogodki
Earnings
Upcoming earnings report